These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3092559)

  • 1. Immunological study of glycolipoprotein isolated from extracellular slime of different Pseudomonas aeruginosa serogroups.
    Stanislavsky ES; Kholodkova EV; Youshkova NA; Yourokova IB; Zhvanetskaya MI
    Acta Microbiol Hung; 1986; 33(1):55-67. PubMed ID: 3092559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological study of Pseudomonas aeruginosa extracellular slime.
    Stanislavsky ES; Yushkova NA; Edvabnaya LS; Landsman NM; Zaidner IG
    Acta Microbiol Hung; 1985; 32(1):49-59. PubMed ID: 2412390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serologic and protective cross-reactivity of antisera to Pseudomonas aeruginosa extracellular slime glycolipoprotein.
    Yushkova NA; Kholodkova EV; Korobova TS; Stanislavsky ES
    Acta Microbiol Hung; 1986; 33(2):147-56. PubMed ID: 3101393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. II. Induction of heterologous immunity by mucoid strains of P. aeruginosa.
    Gościniak G; Grzybek-Hryncewicz K
    Arch Immunol Ther Exp (Warsz); 1988; 36(2):185-93. PubMed ID: 3149177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. I. Induction of homologous immunity by nonmucoid strains of P. aeruginosa.
    Gościniak G; Grzybek-Hryncewicz K
    Arch Immunol Ther Exp (Warsz); 1988; 36(2):177-84. PubMed ID: 2467637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical alterations in the mouse induced by Pseudomonas aeruginosa and its slime glycolipoprotein.
    Lynn M; Lotz L
    Br J Exp Pathol; 1984 Apr; 65(2):275-81. PubMed ID: 6424696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. III. Polyvalent serum against three mucoid immunotypes potentiates phagocytosis of all (7) mucoid immunotypes.
    Gościniak G; Grzybek-Hryncewicz K
    Arch Immunol Ther Exp (Warsz); 1988; 36(2):195-203. PubMed ID: 3149178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histologic study of corneal lesions caused by the slime-GLP glycolipoprotein of Pseudomonas aeruginosa].
    Pharmakakis N; Papadakis E; Gartaganis S; Bechrakis M; Dimitracopoulos G; Varakis I
    Ophtalmologie; 1990; 4(1):72-5. PubMed ID: 2123533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Protective cross activity of the extracellular mucus of Pseudomonas aeruginosa].
    Stanislavskiĭ ES; Iushkova NA; Landsman NM
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Jun; (6):72-7. PubMed ID: 6412492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outer membrane proteins of Pseudomonas aeruginosa as vaccine candidates.
    von Specht BU; Domdey H; Schödel F; Blum B; Lücking C; Knapp B; Muth G; Hungerer KD; Bröker M
    Behring Inst Mitt; 1994 Dec; (95):85-96. PubMed ID: 7538752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of the biologic activity of surface slime in experimental Pseudomonas aeruginosa infections.
    Bartell PF
    Rev Infect Dis; 1983; 5 Suppl 5():S971-8. PubMed ID: 6419319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization of young African green monkeys with OprF epitope 8-OprI-type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa.
    Weimer ET; Ervin SE; Wozniak DJ; Mizel SB
    Vaccine; 2009 Nov; 27(48):6762-9. PubMed ID: 19744586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective activity of immune sera against extracellular slime from Pseudomonas aeruginosa on experimental infection in mice.
    Sokalska M; Maresz-Babczyszyn J
    Arch Immunol Ther Exp (Warsz); 1981; 29(5):643-52. PubMed ID: 6812542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation on extracellular slime from Pseudomonas aeruginosa as interferon inducer in mice.
    Cembrzyńska-Nowak M; Czarny A
    Arch Immunol Ther Exp (Warsz); 1988; 36(2):167-76. PubMed ID: 2467636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common protective antigen (OEP) of Pseudomonas aeruginosa.
    Abe C; Shionoya H; Hirao Y; Okada K; Homma JY
    Jpn J Exp Med; 1975 Oct; 45(5):355-9. PubMed ID: 817054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein.
    Sheth HB; Glasier LM; Ellert NW; Cachia P; Kohn W; Lee KK; Paranchych W; Hodges RS; Irvin RT
    Biomed Pept Proteins Nucleic Acids; 1995; 1(3):141-8. PubMed ID: 9346845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse-protection experience with monovalent Pseudomonas aeruginosa vaccine.
    Sourek J; Výmola F; Zelenková L
    Zentralbl Bakteriol A; 1980 Mar; 246(3):353-62. PubMed ID: 6775443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigations on the immunogenicity of Pseudomonas seruginosa strains of different serological O-groups].
    Meitert E; Meitert T
    Zentralbl Bakteriol Orig; 1968; 208(4):515-21. PubMed ID: 5000090
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemical composition of the extracellular slime glycolipoprotein of Pseudomonas aeruginosa and its relation to gentamicin resistance.
    Arsenis G; Dimitracopoulos G
    J Med Microbiol; 1986 May; 21(3):199-202. PubMed ID: 3084789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction in mice of cell-mediated immunity to Pseudomonas aeruginosa by high molecular weight polysaccharide and vinblastine.
    Pier GB; Markham RB
    J Immunol; 1982 May; 128(5):2121-5. PubMed ID: 6174622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.